Radiotherapy has long been the mainstay of treatment for patients with head and neck
cancer and has traditionally involved a stage-dependent strategy whereby all patients with …

There has been a substantial rise in the utilization of large databases in radiation oncology
research. The advantages of these datasets include a large sample size and inclusion of a …

Background Stereotactic body radiotherapy (SBRT) has become the standard of care for
medically inoperable patients with peripherally located, early stage non-small cell lung …

Background: Stereotactic body radiotherapy (SBRT) has been adopted as the standard of
care for inoperable early-stage non-small cell lung cancer (NSCLC), with local control rates …

Introduction We report results from a prospective phase I/II trial for patients with centrally
located, early-stage NSCLC receiving stereotactic body radiation therapy. Methods Eligible …

Background: Increasing evidence indicates a relationship between systemic inflammation
and survival following treatment in various tumors. However, the correlation of systematic …

Background and purpose Central lung SABR is less established due to toxicity concerns.
We describe plan quality and clinical outcomes for patients treated with VMAT SABR using …

Background: Stereotactic body radiotherapy (SBRT) superseded conventional radiotherapy
(CRT) for the treatment of patients with inoperable early stage non-small cell lung cancer …

Background The optimal treatment of stage I non–small-cell lung carcinoma is subject to
debate. The aim of this study was to compare overall survival and oncologic outcomes of …

Background Stereotactic body radiation therapy (SBRT) and radiofrequency ablation (RFA)
are recommended for patients with inoperable early-stage non-small cell lung cancer …